Carlo Pergola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Carlo Pergola has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Malte Meppen
GSK, Via Fiorentina 1, 53100 Siena, Italy
2 shared publications - Agnese Marcelli
Technical & Research Development, Drug Product, GSK, 53100 Siena, Italy
1 shared publication - Agnese Marcelli
GSK, Via Fiorentina 1, 53100 Siena, Italy
1 shared publication - Alessandro Paglianti
Department of Industrial Chemistry “Toso Montanari” University of Bologna Bologna Italy
1 shared publication - Alessio Moriconi
GSK, Via Fiorentina 1, 53100 Siena, Italy
1 shared publication - Andrea Albano
School of Chemical Engineering, University of Birmingham, Birmingham B15 2TT, UK
1 shared publication
Latest Publications
- Open Access
- 25 July 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (4) , 1-16
Electrical Resistance Tomography (ERT) Proves a Reliable Process Analytical Technology (PAT) for Real-Time Monitoring of Solid-Liquid Suspension and Deposition in Pharmaceutical Processing
Introduction: Aluminum-based adjuvants are widely utilized in vaccines; however, they present specific processing challenges due to their tendency to sediment, necessitating thorough mixing and resuspension to ensure homogeneity. Materials and methods: This study investigates the use of Electrical Resistance Tomography (ERT) as a non-invasive monitoring technique for solid-liquid suspensions, overcoming the limitations of optical methods in opaque systems. A laboratory-scale stirred tank was used to analyze the resuspension behavior of hydrous magnesium silicate, which was selected as a mimic solid due to its similar density and particle size distribution to aluminum hydroxide. Discussion: ERT measurements using multiple circular electrode probes demonstrated reliable quantitative detection of solid volume fractions above 5% v/v, consistent with previous research. Below this threshold, only qualitative analysis is reliable at the cost of quantitative accuracy. Notably, in the fully settled state, an unexpected increase in conductivity was observed in the lower electrode planes, suggesting that electrode-solid interactions affected the reconstructed conductivity field. This hypothesis was further validated through experiments with glass beads, where coverage of specific electrodes led to similar conductivity artefacts. Conclusions: The implementation of a linear probe markedly improved the detection of deposited solids at low overall volume fractions but elevated local concentrations, demonstrating a clear correlation between electrode surface coverage and conductivity signal saturation. These findings confirm the viability of ERT for real-time suspension monitoring, demonstrating its potential for detecting solid accumulation and optimizing mixing in industrial and pharmaceutical processes, including vaccine manufacturing.
- 25 July 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (4) , 1-16
Open AccessElectrical Resistance Tomography (ERT) Proves a Reliable Process Analytical Technology (PAT) for Real-Time Monitoring of Solid-Liquid Suspension and Deposition in Pharmaceutical Processing
Introduction: Aluminum-based adjuvants are widely utilized in vaccines; however, they present specific processing challenges due to their tendency to sediment, necessitating thorough mixing and resuspension to ensure homogeneity. Materials and methods: This study investigates the use of Electrical Resistance Tomography (ERT) as a non-invasive monitoring technique for solid-liquid suspensions, overcoming the limitations of optical methods in opaque systems. A laboratory-scale stirred tank was used to analyze the resuspension behavior of hydrous magnesium silicate, which was selected as a mimic solid due to its similar density and particle size distribution to aluminum hydroxide. Discussion: ERT measurements using multiple circular electrode probes demonstrated reliable quantitative detection of solid volume fractions above 5% v/v, consistent with previous research. Below this threshold, only qualitative analysis is reliable at the cost of quantitative accuracy. Notably, in the fully settled state, an unexpected increase in conductivity was observed in the lower electrode planes, suggesting that electrode-solid interactions affected the reconstructed conductivity field. This hypothesis was further validated through experiments with glass beads, where coverage of specific electrodes led to similar conductivity artefacts. Conclusions: The implementation of a linear probe markedly improved the detection of deposited solids at low overall volume fractions but elevated local concentrations, demonstrating a clear correlation between electrode surface coverage and conductivity signal saturation. These findings confirm the viability of ERT for real-time suspension monitoring, demonstrating its potential for detecting solid accumulation and optimizing mixing in industrial and pharmaceutical processes, including vaccine manufacturing.
- Open Access
New High-Throughput Method for Aluminum Content Determination in Vaccine Formulations
Objective: This manuscript describes an innovative, non-destructive, high-throughput method for the quantification of aluminum hydroxide in aluminum-adjuvanted vaccines, eliminating the need of reagents and providing real-time results. The method is based on a spectrophotometric principle, and several model proteins were studied and tested with the aim to simulate the behavior of aluminum-adjuvanted antigens. Methods: As a proof of concept, the MenB vaccine was used, and the titration of aluminum hydroxide (AH) with ethylenediaminetetraacetic acid (EDTA) was used as an orthogonal reference, as it is one of the current release methods for the content determination of aluminum-hydroxide-adjuvanted vaccine drug products (DPs). The factors influencing the spectrophotometric analysis, such as different plate 96/well containers, variation in the sedimentation of the suspension due to component addition errors during formulation, and batch-to-batch variation were studied to assess the method’s robustness. Five concentration levels (ranging from 2.0 to 4.0 mg/mL AH) with two different batches of aluminum hydroxide were each measured with independent preparations performed by three different operators, for a total of four sessions/operator and 20 formulations/session. An in-depth statistical study was carried out with generated data to assess the precision (in terms of intermediate precision and repeatability), accuracy, linearity, and specificity of the method. Results: The novel spectrophotometric method and the official release one (potentiometric) yielded comparable results, demonstrating the potential of this new method as a release test for AH-adjuvanted products. A simple calibration curve enabled the measurement of samples in a 96-well plate in just a few minutes. Conclusions: We developed a novel method for Aluminum concentration determination in Aluminum-containing pharmaceutical products, like alum-adjuvanted vaccines. This method is fast, completely automatable, and as precise and accurate as already-in-place release methods.
Open AccessNew High-Throughput Method for Aluminum Content Determination in Vaccine Formulations
Objective: This manuscript describes an innovative, non-destructive, high-throughput method for the quantification of aluminum hydroxide in aluminum-adjuvanted vaccines, eliminating the need of reagents and providing real-time results. The method is based on a spectrophotometric principle, and several model proteins were studied and tested with the aim to simulate the behavior of aluminum-adjuvanted antigens. Methods: As a proof of concept, the MenB vaccine was used, and the titration of aluminum hydroxide (AH) with ethylenediaminetetraacetic acid (EDTA) was used as an orthogonal reference, as it is one of the current release methods for the content determination of aluminum-hydroxide-adjuvanted vaccine drug products (DPs). The factors influencing the spectrophotometric analysis, such as different plate 96/well containers, variation in the sedimentation of the suspension due to component addition errors during formulation, and batch-to-batch variation were studied to assess the method’s robustness. Five concentration levels (ranging from 2.0 to 4.0 mg/mL AH) with two different batches of aluminum hydroxide were each measured with independent preparations performed by three different operators, for a total of four sessions/operator and 20 formulations/session. An in-depth statistical study was carried out with generated data to assess the precision (in terms of intermediate precision and repeatability), accuracy, linearity, and specificity of the method. Results: The novel spectrophotometric method and the official release one (potentiometric) yielded comparable results, demonstrating the potential of this new method as a release test for AH-adjuvanted products. A simple calibration curve enabled the measurement of samples in a 96-well plate in just a few minutes. Conclusions: We developed a novel method for Aluminum concentration determination in Aluminum-containing pharmaceutical products, like alum-adjuvanted vaccines. This method is fast, completely automatable, and as precise and accurate as already-in-place release methods.
- Open Access
Maturation of Aluminium Adsorbed Antigens Contributes to the Creation of Homogeneous Vaccine Formulations
Although aluminium-based vaccines have been used for almost over a century, their mechanism of action remains unclear. It is established that antigen adsorption to the adjuvant facilitates delivery of the antigen to immune cells at the injection site. To further increase our understanding of aluminium-based vaccines, it is important to gain additional insights on the interactions between the aluminium and antigens, including antigen distribution over the adjuvant particles. Immuno-assays can further help in this regard. In this paper, we evaluated how established formulation strategies (i.e., sequential, competitive, and separate antigen addition) applied to four different antigens and aluminium oxyhydroxide, lead to formulation changes over time. Results showed that all formulation samples were stable, and that no significant changes were observed in terms of physical-chemical properties. Antigen distribution across the bulk aluminium population, however, did show a maturation effect, with some initial dependence on the formulation approach and the antigen adsorption strength. Sequential and competitive approaches displayed similar results in terms of the homogeneity of antigen distribution across aluminium particles, while separately adsorbed antigens were initially more highly poly-dispersed. Nevertheless, the formulation sample prepared via separate adsorption also reached homogeneity according to each antigen adsorption strength. This study indicated that antigen distribution across aluminium particles is a dynamic feature that evolves over time, which is initially influenced by the formulation approach and the specific adsorption strength, but ultimately leads to homogeneous formulations.
Open AccessMaturation of Aluminium Adsorbed Antigens Contributes to the Creation of Homogeneous Vaccine Formulations
Although aluminium-based vaccines have been used for almost over a century, their mechanism of action remains unclear. It is established that antigen adsorption to the adjuvant facilitates delivery of the antigen to immune cells at the injection site. To further increase our understanding of aluminium-based vaccines, it is important to gain additional insights on the interactions between the aluminium and antigens, including antigen distribution over the adjuvant particles. Immuno-assays can further help in this regard. In this paper, we evaluated how established formulation strategies (i.e., sequential, competitive, and separate antigen addition) applied to four different antigens and aluminium oxyhydroxide, lead to formulation changes over time. Results showed that all formulation samples were stable, and that no significant changes were observed in terms of physical-chemical properties. Antigen distribution across the bulk aluminium population, however, did show a maturation effect, with some initial dependence on the formulation approach and the antigen adsorption strength. Sequential and competitive approaches displayed similar results in terms of the homogeneity of antigen distribution across aluminium particles, while separately adsorbed antigens were initially more highly poly-dispersed. Nevertheless, the formulation sample prepared via separate adsorption also reached homogeneity according to each antigen adsorption strength. This study indicated that antigen distribution across aluminium particles is a dynamic feature that evolves over time, which is initially influenced by the formulation approach and the specific adsorption strength, but ultimately leads to homogeneous formulations.